Вы находитесь на странице: 1из 17

Curriculum in Cardiology

Appropriate Cardiac Cath Lab activation: Optimizing electrocardiogram interpretation and clinical decisionmaking for acute ST-elevation myocardial infarction
Ivan C. Rokos, MD, a William J. French, MD, b Amal Mattu, MD, c Graham Nichol, MD, d Michael E. Farkouh, MD, MSc, e James Reiffel, MD, f and Gregg W. Stone, MD f Los Angeles, CA; Baltimore, MD; Seattle, WA; Toronto, ON; and New York, NY

During the last few decades, acute ST-elevation on an electrocardiogram (ECG) in the proper clinical context has been a reliable surrogate marker of acute coronary occlusion requiring primary percutaneous coronary intervention (PPCI). In 2004, the American College of Cardiology/American Heart Association ST-elevation myocardial infarction (STEMI) guidelines specified ECG criteria that warrant immediate angiography in patients who are candidates for primary PPCI, but new findings have emerged that suggest a reappraisal is warranted. Furthermore, as part of integrated and efficient STEMI systems, emergency department and emergency medical services providers are now encouraged to routinely make the time-sensitive diagnosis of STEMI and promptly activate the cardiac catheterization laboratory (Cath Lab) team. Our primary objective is to provide a practical summary of updated ECG criteria for emergency coronary angiography with planned PPCI, thus allowing clinicians to maximize the rate of appropriate Cath Lab activation and minimize the rate of inappropriate Cath Lab activation. We review the evidence for ECG interpretation strategies that either increase diagnostic specificity for classic STEMI and left bundlebranch block or improve diagnostic sensitivity in identifying 4 STEMI-equivalents: posterior MI, acute left main occlusion, de Winter ST/T-wave complex, and certain scenarios of resuscitated cardiac arrest. (Am Heart J 2010;160:995-1003.e8.)

The key trigger point for emergency cardiac catheterization laboratory (Cath Lab) activation is usually a single electrocardiogram (ECG) diagnostic of an acute ST-elevation myocardial infarction (STEMI), which instantly reclassifies a patient with chest pain or other acute cardiac symptoms from routine evaluation status to high-priority STEMI procedure (Figure 1). The 2004 American College of Cardiology/American Heart Association (ACC/AHA) guidelines1 specify ECG criteria that warrant immediate angiography in patients who are candidates for primary percutaneous coronary intervention (PPCI). Although new findings related to the ECG

From the aUCLA-Olive View, Department of Emergency Medicine, Los Angeles, CA, b Harbor-UCLA, Division of Cardiology, Department of Medicine, Los Angeles, CA, c University of Maryland, Department of Emergency Medicine, Baltimore, MD, dUniversity of Washington-Harborview Center for Pre-Hospital Emergency Care, Seattle, WA, e University Health Network and Li Ka Shing Knowledge Institute, Toronto, ON, and f Columbia University Medical Center and the Cardiovascular, Research Foundation, New York, NY. Submitted March 29, 2010; accepted August 12, 2010. Reprint requests: Ivan C. Rokos, MD, FACEP, FAHA, (FACC), UCLA-Olive View Medical Center, Department of Emergency Medicine, North Annex, 14445 Olive View Drive, Sylmar, CA 91342-1495. E-mail: irokos@earthlink.net 0002-8703/$ - see front matter 2010, Mosby, Inc. All rights reserved. doi:10.1016/j.ahj.2010.08.011

diagnosis of STEMI have emerged since 2004, they have not been reviewed by any of the more recent guidelines.2-6 Hence, our primary objective is to provide a practical summary of updated criteria for emergency coronary angiography with planned PPCI, thus allowing clinicians to maximize the rate of appropriate Cath Lab activation and minimize the rate of inappropriate Cath Lab activation. Three background concepts are important. First, ECG analysis is a fundamental clinical skill that is used routinely by a broad range of clinicians, but high-risk ECG findings consistent with acute ischemia continue to be overlooked.7 Second, a common efficiency challenge involves the need to quickly differentiate and treat the small cohort of acute STEMI patients from the much larger group of undifferentiated chest pain patients (Figure 1). This must be balanced against the potential for poor resource utilization, especially with the current emphasis on early Cath Lab activation by either emergency department (ED) or emergency medical services providers.8,9 Third, a coordinated systems-based approach is currently emphasized by the ACC/AHA STEMI guidelines,2,3 the ACC Door-2-Balloon (D2B) Alliance,10 and the AHA Mission: Lifeline initiative.11 Proposed efforts within Mission:Lifeline12 to comprehensively track all Cath Lab activations and improve overall STEMI system efficiency depend on the existence of clearly

996 Rokos et al

American Heart Journal December 2010

Figure 1

STEMI Process #1 empowers frontline providers (ED triage nurses and paramedics) to promptly perform an ECG on all suspected cardiac patients. The STEMI Diagnosis by 12-lead electrocardiography is the key trigger point for a series of events designed to rapidly restore blood flow in an acutely occluded coronary. The STEMI Process #2 includes all the treatments provided in the time interval from STEMI diagnosis to patient arrival in the Cath Lab. The Cath Lab STEMI Procedure begins with emergency coronary angiography, followed by PPCI and other invasive procedures as indicated. STEMI Process #3 represents active participation in a quality improvement registry for the entire system.

defined criteria that distinguish appropriate versus inappropriate Cath Lab activation. To maximize appropriate Cath Lab activations, we critically review and summarize (Tables I and II) real-time ECG interpretation strategies that accurately identify both STEMI and STEMI-equivalents. Criteria defining the term STEMI-equivalent have been gradually standardized by both the National Cardiovascular Data Registry (NCDR) data dictionaries and international consensus,13 and broadly include any ECG pattern potentially associated with an acute coronary occlusion but lacking classic ST-elevation. Efficient STEMI systems of care need to maximize diagnostic specificity for both classic STEMI ECG patterns and new (or presumed new) left bundlebranch block (ie, a STEMI-equivalent), whereas diagnostic sensitivity should be improved in identifying 4 additional STEMI-equivalents: posterior MI, acute left main occlusion, de Winter ST/T-wave complex, and certain scenarios of resuscitated cardiac arrest. Moreover, we propose that clinicians conceptually prioritize 3 questions when analyzing any ECG: (1) Are the ST-segments consistent with acute STEMI or STEMI-equivalent? (2) Has chronic ST-segment elevation that does not represent acute myocardial infarction been excluded? (3) Is the patient a reasonable candidate for reperfusion therapy (PPCI or fibrinolytics)?

Definitions and background concepts


Acute myocardial infarction can be defined from various clinical perspectives: electrocardiography, biomarkers, angiography, imaging, and pathology.14 However, the 2004 guidelines1 emphasize the central role of the ECG in decision-making during the acute phase and define classic STEMI as 1 mm ST-elevation in 2 adjacent leads (class I-A recommendation). Acute and persistent ST-elevation, meeting these criteria in either leads V1 through V4 or leads II/III/aVF, represents the

most common (80%) ECG finding that is customarily reported, respectively, as an infarction of the anterior or inferior region of the heart in registries, clinical trials, and the International Classification of Diseases, Ninth Revision, billing codes. As specified in a recent expert consensus document,15 actual ECG leads should not be simply referred to as anterior or inferior because this de-emphasizes the important bioelectric principle that all ECG leads are bipolar. Thus, an acute coronary occlusion can manifest on any of the 12 individual leads of a standard ECG with either ST-elevation at the positive pole or ST-depression at the negative pole. For example, leads V1 through V3 might be designated most accurately as anteroseptal-posterolateral bipolar leads. This provides the rationale for designating certain types of ST-depression ECG patterns as true STEMI-equivalents (eg, posterior MI, acute left main occlusion, de Winter ST/T-wave complex). Because current guidelines1 state that timely PPCI is the preferred reperfusion modality, our review has principally focused upon appropriate Cath Lab activation criteria. However, in many STEMI-care settings, prompt administration of fibrinolytics represents the only realistic reperfusion option for an acute coronary occlusion per the guidelines.1 Fortunately, initial ECG interpretation strategies for detecting acute STEMI or STEMI-equivalent are similar for treatment pathways involving either PPCI or fibrinolysis, but safe fibrinolytic administration also requires review of a standardized Contraindications Checklist.1

Maximizing diagnostic specificity for acute coronary occlusion


Classic STEMI In the proper clinical context, acute ST-elevation 1 mm in 2 contiguous ECG leads represents a reliable surrogate marker for an acute coronary occlusion

American Heart Journal Volume 160, Number 6

Rokos et al 997

Table I. Comparison of 2004 ACC/AHA guidelines and authors' proposed update for ECG criteria that enhance the rate of appropriate Cath Lab activation for acute MI
Indications for appropriate Cath Lab activation Classic STEMI Anterior Diagnostic criteria for patients with symptoms <12 h 2004 ACC/AHA guideline recommendation Proposed update vs. ACC/AHA guidelines

Comment

ST-elevation 1 mm in 2 contiguous leads V1-V4

Class I-A

Agree

Inferior

Lateral

ST-elevation 1 mm in 2 contiguous leads (II, III, or AVF) ST-elevation 1 mm in 2 contiguous leads (I, AVL, V5, or V6)

Class I-A

Agree

Class I-A

Agree

ST-elevation 2 mm (men) and 1.5 mm (women) improves diagnostic specificity.15 Presence of reciprocal changes (ST-depression in opposite leads) improves diagnostic specificity. Presence of reciprocal changes improves diagnostic specificity. As above.

STEMI-equivalents New or presumed new-onset LBBB

Proposed demotion in future Unless clinically unstable, ACC/AHA guidelines most LBBB should be evaluated with biomarkers and non-emergent angiography if indicated. An old ECG without LBBB does not necessarily confirm that the new LBBB is acute. None Proposed addition to future Use of these decision criteria Preexisting LBBB with Concordance noted between ACC/AHA guidelines provides N95% specificity Sgarbossa concordance QRS complex and ST/T-wave and avoids the need to find a complex, with ST elevation prior ECG for comparison. 1 mm in 1 lead Discordant ST-elevation 5 mm is also a Sgarbossa criteria, but some studies found it a weak predictor. Posterior MI (isolated) ST-depression 0.5 mm in Fibrinolytics: class IIa-C Proposed clarification in Recent data34 demonstrated leads V1-V3 Primary PCI: class I-A implied future ACC/AHA guidelines that most posterior MIs are currently evaluated with Associated T-waves are either urgent (rather than upright or inverted. emergent) angiography, but Appearance of tall R-waves this delay is associated with in V1-V2 may be delayed. worse clinical outcomes. Left Main coronary ST-depression 1 mm in None Proposed addition to future Most relevant in any ECG occlusion 6 or more leads ACC/AHA guidelines with diffuse ST-depression Lead aVR with ST-elevation 1 mm 1 mm that does not meet ST-elevation in lead aVR V1 classic STEMI criteria, thus providing a subtle clue that emergency angiography may be warranted de Winter ST/T-wave ST depression 1 mm None Proposed addition to future Tall T waves and up-sloping complex up-sloping at the J-point in ACC/AHA guidelines ST depression are persistent, leads V1-V6 not transient. Precordial T waves are tall, Associated with proximal upright, symmetric LAD occlusion Normal QRS duration None Potential addition to future Generally prudent to perform Hyper-acute T-waves Tall peaked T waves ACC/AHA guidelines serial ECGs, because true immediately following HATW generally morph symptom onset may quickly into a classic STEMI represent acute ischemia, pattern13 but clinical studies are lacking. Hyperkalemia is another common cause of tall T waves

Presumed new LBBB assumed when prior ECG unavailable New LBBB when prior ECG available

Class I-A

998 Rokos et al

American Heart Journal December 2010

Table II. Three scenarios for appropriate Cath Lab activation involving out-of-hospital cardiac arrest (OHCA)
First event Acute STEMI diagnosed by prehospital ECG Second event Cardiac arrest witnessed by EMS providers, followed by prompt defibrillation and ROSC Shockable rhythm and ROSC achieved, followed by ECG diagnostic of acute STEMI or STEMI-equivalent Shockable rhythm and ROSC achieved, but postresuscitation ECG is not diagnostic of acute STEMI or STEMI-equivalent Action Cath Lab team at STEMI receiving center should have already been activated based on original diagnosis of STEMI or STEMI-equivalent Activate Cath Lab team at cardiac resuscitation center Supplemental action Initiate hypothermia protocol in postresuscitation patients who remain unconscious Same as above

Bystander witnessed OHCA, early activation of 9-1-1, and early chest compressions Same as above

Consider activation of Cath Lab team at cardiac resuscitation center in patients whose clinical circumstance suggests acute ischemia and who are candidates for aggressive intervention

Same as above

EMS, Emergency medical services.

requiring PPCI (Table I and online Appendix items I.a-d). However, ECG accuracy may be limited by multiple conditions: large individual variations in coronary anatomy, preexisting disease, collateral circulation, misplaced leads, and technical shortcomings in detecting electrical impulses from certain regions of the heart.15,16 Inappropriate Cath Lab activations have a number of negative implications, including poor resource utilization, unnecessary costs, patient safety risk, increased patient anxiety, work-life-sleep issues that may adversely affect career longevity of Cath Lab staff (ie, burn-out), and potential community risk from entire Cath Lab teams rushing (ie, driving fast) back to the hospital to treat an after-hours STEMI. Initial reports of ED physician performance in diagnosing acute STEMI identified a 9% rate of false-positive Cath Lab activation (no culprit artery and negative biomarkers).17 More recent surveillance of unnecessary Cath Lab activations (ie, cardiologist did not perform emergency coronary angiography) by ED physicians demonstrated a 5% rate from a single-center experience (n = 249 activations) in Virginia18 and a 6% rate across 14 hospitals (n = 2,213 activations) in a North Carolina STEMI system.19 In contrast, evaluation of prehospital-ECG interpretation by paramedics (n = 646) from Los Angeles County, California, found a 20% rate of inappropriate Cath Lab activation (ie, cardiologist did not perform emergency coronary angiography), with an additional 5% of suspected STEMI on PH-ECG that never resulted in Cath Lab activation (although PH-ECG transmission was rarely used).20 Similar analysis (n = 529) from Orange County, California, found a 23% rate of inappropriate Cath Lab activation.21 As proposed previously,22 we believe a <5% rate of inappropriate Cath Lab activation represents a reasonable STEMI systems goal. Table III provides our conceptual framework summarizing appropriate versus inappropriate Cath Lab activation scenarios, recognizing that not all Cath Lab activations classified as appropriate actually result in PPCI. To help clinicians optimize

Table III. Classification of appropriate versus inappropriate Cath Lab activation

Appropriate Cath Lab Activation Ideal


Angiography and PPCI performed

Appropriate Cath Lab Activation Reasonable


Angiography without PPCI performed:
Surgical revascularization indicated Coronary anatomy is not amenable to PPCI intervention (ie, Medical therapy) Unavoidable angiogram per index ECG and/or clinical scenario as documented by the real-time clinicians (eg, Tako-tsubo, myocarditis) No PPCI target-lesion identified but cardiac markers become elevated

Before angiography, true STEMI per index ECG dies suddenly Angiography PPCI for ROSC following witnessed OHCA from a shockable rhythm. Some ROSC patients may deteriorate and die before angiography.

Inappropriate Cath Lab Activation Goal is <5% rate


No Angiography performed (Cath Lab activation cancelled by a physician) Angiography without a PPCI target-lesion identified and normal cardiac markers:
Avoidable angiogram based upon erroneous ECG interpretation

Advanced co-morbidities: Patient is not a PPCI-candidate

Classification based on retrospective and multidisciplinary peer review of all index clinical data. Green zone represents the ideal scenario, yellow zone events are reasonable, and red zone occurrences should be minimized (<5%).

resource utilization in STEMI systems, 6 ECG-interpretation strategies are reviewed below. First, the degree of ST-elevation is a continuous variable that has been stratified (<1 or 1 mm) in the guidelines1 to yield a convenient binary diagnosis (STEMI absent vs. present, respectively). However, evidence exists for increased specificity when diagnostic criteria involve 2 mm ST-elevation in certain precordial leads.6 In recognition of benign ST-elevation that is frequently observed in healthy adults, the NCDR data dictionaries (Cath-PCI v4.3 and ACTION-GWTG v2.1) currently set the STEMI threshold in leads V2-V3 at 2 mm for men and 1.5 mm for women. Similarly, a recent AHA/ACC statement15 in conjunction with the Heart Rhythm Society listed the same criteria (except for men age <40, the threshold is N2.5 mm ST-elevation in leads V2-V3).

American Heart Journal Volume 160, Number 6

Rokos et al 999

Table IV. Common STE-mimics


Narrow QRS Complex STE-mimics Benign early repolarization (BER) Pericarditis Left ventricular aneurysm Normal variant male pattern Preexcitation Tall/Wide QRS Complex STE-mimics Left ventricular hypertrophy (LVH) LBBB Paced rhythm Hyperkalemia Brugada syndrome

A comprehensive list of all STE-mimics already exists.23

Second, clinician awareness regarding the existence of ST-elevation mimics (STE-mimics) is essential and provides the basis for distinguishing pathologic vs. nonpathologic ST-elevation.23 At the minimum, clinician familiarity should exist broadly for 10 common conditions (Table IV and online Appendix items III.a-e) with chronic ST-elevation. Third, the presence of reciprocal changes on the ECG (ie, ST-depression 0.5 mm in leads 180 opposite to those meeting ST-elevation criteria) should exist for all ECGs with acute STEMI based upon bioelectric principles, but this reciprocal ST-depression might be of lesser magnitude or undetectable due to technical limitations of the standard 12-lead ECG.15,16 By definition, reciprocal ST-depression should never occur in ECGs considered normal or those with narrow-complex STE-mimics (except lead aVR with pericarditis). In a fibrinolytic era study,24 the presence of any reciprocal ST-depression in 2 leads was associated with N95% diagnostic specificity and positive predictive value for acute MI. More recently, an AHA scientific statement15 recommended that computerized interpretation algorithms incorporate the location of ST-depression to predict the location of a coronary occlusion. Collectively, these data suggest that clinicians should evaluate every ECG with suspected STEMI for reciprocal changes: if present, then appropriate Cath Lab activation is almost certain; if absent, the presence of a STE-mimic versus a true STEMI without reciprocal changes should be carefully but expeditiously considered. Observation of reciprocal changes may be also be helpful in resolving challenging semi-STEMI cases near the 1-mm threshold, where one clinician may see 1.1 mm of ST-elevation but another sees only 0.9 mm. Fourth, pathologic Q-waves may develop in leads initially demonstrating ST-elevation, and hence their presence supports the diagnosis of true STEMI (but their absence does not exclude acute STEMI).1 Furthermore, a recent APEX-AMI substudy25 analysis of 4,530 patients with 6 hours of symptoms identified 2,514 (56%) with a Q wave (defined as 40 milliseconds [1 mm] duration, excluding lead III) already present on the baseline ECG. Even with contemporary PPCI-based reperfusion, the cohort with Q waves at baseline had

worse outcomes (composite of death, heart failure, or shock at 90 days) after multivariate adjustment. Fifth, a commonly used ECG computer algorithm demonstrated 90% specificity for identifying acute STEMI when evaluated in a clinical trial,26 thus providing a reasonable real-time diagnostic aide for clinicians involved in time-pressured ECG interpretation. However, experience with the computer algorithm for prehospital ECGs as part of regional STEMI networks has demonstrated lower specificity and increased rates of inappropriate Cath Lab activation.9,20,21 Lastly, immediate Wireless transmission and Physician Interpretation (WiPI) of all prehospital-ECGs with suspected STEMI improves the rate of appropriate Cath Lab activation.27 By increasing the number of critical eyes that review an ECG in real-time (simultaneously with patient transport), WiPI can provide an important appropriateness filter between a prehospital STEMI Alert and an in-hospital Code STEMI.9

Left bundle-branch block Left bundle-branch block (LBBB) represents a unique challenge in the acute setting, because it can be categorized as either a STE-mimic or a STEMI-equivalent. As a STE-mimic, chronic LBBB patterns in asymptomatic patients almost always have persistent ST-elevation 1 mm in the anteroseptal and/or inferior leads. However, for decades, new (or presumed new) LBBB has also been considered a STEMI-equivalent that requires prompt therapy, with inclusion in guidelines, clinical trials, NCDR registries, and Joint Commission acute MI core measures. Furthermore, both the ACC/AHA and European guidelines1,5 strongly recommend (class I-A) immediate reperfusion, based predominately on old metaanalysis data showing reduced mortality in fibrinolytictreated LBBB patients.28 Data have gradually accumulated suggesting that traditional criteria using new (or presumed new) LBBB as a STEMI-equivalent results in low diagnostic specificity and high rates of inappropriate Cath Lab activation. For example, a fibrinolytic era study of 7,725 consecutive patients with suspected cardiac ischemia presenting to a single ED found only 182 (2.4%) patients with LBBB on ECG, and only 24 (13%) of the 182 with LBBB had an acute myocardial infarction using positive biomarkers as the gold standard.29 In the modern era, angiographic assessment of presumed new LBBB also raised concerns about treating these patients emergently as a true STEMI-equivalent. A recent single-center PPCI-focused study30 of 7,937 chest pain patients in the ED identified 55 (0.7%) presumed new LBBB, 136 (1.7%) confirmed old LBBB, and 7,746 (97.6%) without LBBB. In the primary analysis comparing the new vs old vs no LBBB cohorts, the rate of biomarker-confirmed acute MI was similarly low (7.3%,

1000 Rokos et al

American Heart Journal December 2010

5.2%, 6.1%, respectively, P = .75). Thus, N90% of LBBB patients evaluated in the ED do not have an acute coronary occlusion nor require PPCI. Similarly, a recent analysis from the PPCI-focused Minneapolis interhospital transfer network17 identified only 36 (2.6%) of 1335 patients with presumed new LBBB. Moreover, 16 (44%) of 36 from this cohort did not have a culprit artery visualized during emergency coronary angiography, and 13 (36%) of 36 had no elevation of serial biomarkers. The latest ESC guidelines5 acknowledge these more recent findings by stating that biomarker results may sometimes be helpful in evaluating LBBB patients, thus implying treatment of stable patients with an urgent rather than emergent PCI strategy. Importantly, clinically unstable LBBB patients or those with acutely abnormal anterior wall motion by echocardiography should still receive emergency angiography. Published ECG criteria (Table I and online Appendix item II.e) exist that maximize diagnostic specificity for detecting a true STEMI-equivalent in the setting of chronic LBBB. A chronic LBBB normally has discordance (the direction of the major component of the QRS complex is opposite that of ST segment/T wave in any lead), whereas QRS/ST concordance (with ST elevation 1 mm in 1 lead) appears to be the most robust predictor of acute ischemia.6,15,31 A recent metaanalysis32 found only 20% sensitivity but 98% specificity for the concordance criteria, but much of the data is from the fibrinolytic era when cardiac markers instead of angiography were the gold standard.

Although replacement terms like posterolateral MI were considered, the expert statement ultimately recommended retaining the term posterior MI for ST-depression 0.5 mm in leads V2 through V3 (or ST-elevation 0.5 mm in leads V7-V9) until additional data become available. The TRITON-TIMI-38 study33 enrolled patients with both STEMI and non-STEMI, and thus it provided a unique opportunity to evaluate contemporary posterior MI therapy. According to a recent substudy,34 isolated ST-depression in leads V1 through V3 on index ECG was present in 1,198 (8.8%) of the 13,608 enrolled patients and retrospectively classified by the core lab as posterior MI (26.2%), non-STEMI (53.5%), and unstable angina (20.3%) based upon cardiac markers and angiography. Despite guideline recommendations,1 the vast majority (1193 [99.6%]) of study patients with isolated ST-depression in leads V1 through V3 were treated with non-emergent PCI (N6 hours after index ECG). However, the cohort of slowly treated posterior MIs had an acutely occluded coronary (most commonly the left circumflex) and had a significantly higher rate of 30-day death or MI as compared with those classified as non-STEMI.

Maximizing diagnostic sensitivity for acute coronary occlusion


Posterior myocardial infarction True posterior MI should be treated as a STEMIequivalent, in which case isolated ST-depression 0.5 mm in leads V1 through V3 represents the dominant finding (Table I and online Appendix item II.a) on a standard 12-lead ECG.6,15 The use of additional posterior chest wall leads (V7-V9 0.5 mm) to detect ST elevation consistent with posterior MI is often recommended,6,15 but their use remains uncommon in daily practice. Clinical trials commonly exclude posterior MI and the guidelines1 reflect this paucity of evidence with a class IIa-C recommendation for administering fibrinolytics in this subset of patients. Paradoxically, the guidelines1 indirectly imply a class I-A recommendation for PPCI of posterior MI. A recent AHA scientific statement15 critiqued the term posterior MI (used in the 2004 ACC/AHA guidelines, clinical trials, NCDR registries, and International Classification of Diseases, Ninth Revision, codes) because the actual infarct occurs in the lateral wall of the left ventricle when assessed by advanced imaging techniques.

Left main coronary occlusion Acute left main coronary occlusion (LMCO) generally causes massive ischemia and is rapidly lethal, but a small proportion of patients have enough perfusion from rightsided collaterals to arrive alive at the hospital. A recent Cath-PCI Registry analysis35 spanning 2004 to 2008 identified 434 (0.35% of all attempted PCIs in Cath-PCI) with acute STEMI from a left main culprit that was unprotected (ie, no prior coronary artery bypass grafting to distal vessels). Interestingly, about one third of patients did not present in cardiogenic shock, even though angiography demonstrated that 85% of these patients had N90% stenosis and 55% had complete LMCO. Importantly, survival to hospital discharge was 42% in this series. STEMI-equivalent ECG criteria (Table I and online Appendix item II.b) exist for diagnosing the critical condition of acute LMCO, but these are not mentioned in any of the guidelines.1-3,5 In 2001, a small series reported that 0.5-mm ST-elevation in lead aVR is consistent with acute LM occlusion, especially when the degree of ST-elevation in aVR is greater than lead V1 and inferior ST-depression is present.36 A combined analysis of 3 studies with a total of 75 acute LM occlusions confirmed by angiography demonstrated N75% sensitivity and specificity for these ECG findings.37 A 2009 AHA scientific statement15 recommended when the resting ECG reveals ST-depression N1 mm in 8 or more surface leads coupled with ST-elevation in aVR and/or VI but is otherwise unremarkable, the automated [computerized] interpretation should suggest ischemia due to multi-vessel or left main coronary artery

American Heart Journal Volume 160, Number 6

Rokos et al 1001

obstruction. A 2010 international consensus document13 provided similar STEMI-equivalent criteria for acute LMCO (or severe angiographic disease): a myocardial ischemia vector causing ST-depression in 6 or more leads (maximal in V4-V6) and associated ST-elevation limited to lead aVR and V1.

de Winter ST/T-wave complex In 2008, de Winter et al38 described a novel STEMIequivalent ECG pattern that signifies acute occlusion of the proximal left anterior descending (LAD). Following examination of their Dutch registry, the de Winter ST/ T-wave pattern was first recognized in 30 unique patients (all with normal baseline serum potassium levels) and represented 2% of all angiographically confirmed anterior MIs. Diagnostic criteria on ECG include 1 to 3 mm of ST-depression that is up-sloping at the J-point in leads V1 through V6 and associated with persistently tall, upright, and symmetric precordial T-waves (Table I and online Appendix item II.c). The de Winter ST/T-wave complex is distinct from transient hyper-acute T-waves (HATW) that may occur within minutes of an acute coronary occlusion (representing another potential STEMI-equivalent ECG pattern) but generally morph quickly into a classic STEMI pattern.13,38 Transient HATW can be induced with experimental occlusion of a coronary for a few minutes, but they have not been used as inclusion criteria for STEMI clinical trials. In addition, de Winter ST/T-wave complex should not be confused with Wellens syndrome,39 in which the ECG demonstrates either biphasic or inverted T waves in leads V2 through V3 (online Appendix item II.d). Wellens syndrome typically involves a chronic highgrade LAD stenosis that can usually be evaluated by nonemergent angiography. Resuscitated cardiac arrest For more than a decade, it has been known that approximately 50% of patients with out-of-hospital cardiac arrest (OHCA) and return of spontaneous circulation (ROSC) have an acute coronary artery occlusion when evaluated by immediate diagnostic angiography.40 Hence, in addition to the acute STEMI and STEMI-equivalent ECG criteria (Table I) reviewed thus far, certain scenarios of OHCA with ROSC appear to be gaining acceptance as a trigger for appropriate Cath Lab activation (Table II). Many OHCA patients simply represent a dramatic presentation of an acute coronary occlusion, with sudden death as both the chief complaint and the clinical STEMI-equivalent. Neither the ACC/AHA guidelines nor the European guidelines1-3,5 comment on the role of immediate diagnostic coronary angiography for OHCA patients, but both acknowledge that most of

the deaths in STEMI patients occur from lethal arrhythmias within 1 to 2 hours of symptom onset. Historically, the practice of taking resuscitated OHCA patients for emergency coronary angiography and planned PPCI was rare and usually restricted to a small cohort of ideal patients: witnessed arrest, early chest compressions, early defibrillation of a shockable rhythm (ventricular tachycardia or fibrillation), early ROSC, hemodynamically and electrically stable on arrival to the hospital, and clinically perceived on initial assessment to have experienced only minimal neurologic injury from ischemia. Although randomized controlled trials of STEMI almost uniformly exclude OHCA, observational registry data has gradually accumulated and demonstrated good outcomes in resuscitated OHCA patients who traditionally have been considered less than ideal candidates for Cath Lab intervention. Thus, both the 2008 International Liaison Committee on Resuscitation41 consensus statement and the 2009 state-of-the-art paper by Ewy and Kern42 recommended aggressive postresuscitation care involving both PPCI and invasive hemodynamic support for a greater proportion of patients resuscitated from OHCA. Despite the International Liaison Committee on Resuscitation consensus statement, controversy still exists regarding the ability of a postresuscitation ECG to identify patients with an acute coronary occlusion.43,44 However, the largest experience to date is the PROCAT45 registry, which provided compelling new evidence supporting a routine Cath Lab based treatment pathway for OHCA regardless of ECG pattern after resuscitation. In the PROCAT registry spanning 2003 to 2008, all 435 resuscitated OHCA patients with no obvious extracardiac cause of arrest received emergency coronary angiography. Of the 134 patients with a post-ROSC ECG demonstrating classic STEMI, 128 (96%) had at least one significant lesion (N50% reduction in luminal diameter) and 99 (74%) underwent successful PCI. In the remaining 301 patients without classic STEMI on post-ROSC ECG, 176 (58%) had a significant lesion and 78 (26%) received PCI. Multivariable analysis demonstrated successful PCI to be an independent predictor of survival (OR 2.1, 95% CI 1.2-3.7), irrespective of postresuscitation ECG pattern. As compared to a historically low rate of survival (<10%),41 overall survival to hospital discharge was 40% in the PROCAT registry. Moreover, there was a 94% rate of favorable neurologic outcomes in a cohort with a 68% rate of shockable first rhythm and 85% rate of in-hospital therapeutic hypothermia. A recent AHA policy statement proposed the development of cardiac resuscitation centers46 in association with an existing network of STEMI receiving centers.11,22 The statement emphasized that optimal postresuscitation care is complex, multi-disciplinary, and is probably most efficiently provided in designated hospitals via a coordinated systems-based approach that is supported by a robust quality improvement infrastructure. Three different

1002 Rokos et al

American Heart Journal December 2010

prehospital scenarios warrant consideration with regard to appropriate Cath Lab activation (Table II). Furthermore, within each general scenario, real-world clinical decision-making likely involves assessment of the down time before initiation of certain critical prehospital interventions (ie, time delay from patient collapse to 9-1-1 call, to chest compressions, and to defibrillation) and each patient's clinical status upon hospital arrival.

elevation on ECG (eg, STEMI-equivalents and certain OCHA scenarios), not all ST-elevation patterns represent true STEMI (ie, STE-mimics), and some true STEMI patients are not reasonable candidates for an aggressive treatment strategy involving PPCI. Optimal ECG interpretation proficiency by all clinicians in identifying both classic STEMI and STEMI-equivalents constitutes a major cornerstone of ongoing efforts to maximize STEMI system efficiency.

Appropriate patient selection


The final decision point before a Cath Lab activation involves clinical correlation, and hence our deliberate use of the term appropriate Cath Lab activation. This broader term includes both traditional false-positive Cath Lab activation (ie, technical competency in ECG interpretation for STEMI and STEMI-equivalents) as well as physician judgment regarding whether or not an individual patient is a candidate (class I-A recommendation1) for PPCI. Identification of STEMI and STEMI-equivalent patients for whom Cath Lab activation is inappropriate requires frontline physicians to document a brief yet careful assessment of the overall clinical scenario, age, comorbidities, functional status, do-not-resuscitate status, family perspective, and patient preferences. New findings are also informing appropriate patient selection strategies in patients resuscitated from sudden cardiac arrest. Interest in early Cath Lab activation and PPCI-based myocardial reperfusion has traditionally been overshadowed by significant concerns regarding meaningful neurologic recovery from the initial anoxic insult. However, data have gradually accumulated from both clinical trials and observational registries supporting the ability of therapeutic hypothermia to significantly improve the rate of good cerebral recovery (number needed to treat = 6).41,46 Thus, baseline neurologic status immediately after ROSC should not preclude early Cath Lab activation because current AHA expert statements41,46 emphasize deferral of cerebral recovery prognostication for at least 72 hours after collapse in patients treated with therapeutic hypothermia. Furthermore, although the best hypothermia protocol has yet to be definitively proven, current consensus41,46 suggests initiating cooling as early as possible (ie, pre-arrival to the Cath Lab) using some approximation of a 4/24/8/@33 protocol (4-hour induction [1/h]) to a target temperature of 33, 24-hour maintenance at 33 with minimal temperature variation, and 8 hours of rewarming (0.5/h) back to normothermia.

Disclosures
No external funding sources supported the writing of this manuscript. Dr Stone reports research support from Boston Scientific, Abbott Vascular, TherOx, and The Medicines Company; consultant to St Jude Medical and Radiant; honoraria from Eli Lilly, Medtronic, and GlaxoSmith-Kline. The remaining authors do not have financial or industry relationship disclosures relevant to this article.

References
1. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (committee to revise the 1999 guidelines). J Am Coll Cardiol 2004;44:671-719. 2. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol 2008;51: 210-47. 3. Kushner FG, Hand M, Smith SC, et al. Focused update: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating 2004 guidelines and 2007 focused update). JACC 2009;54:2205-41. 4. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/ AHA/ASNC 2009 appropriateness criteria for coronary revascularization. J Am Coll Cardiol 2009;53:530-53. 5. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent STsegment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-45. 6. Fesmire FM, Brady WJ, Hahn S, et al. ACEP clinical policy: indications for reperfusion therapy in emergency department patients with suspected acute myocardial infarction. Ann Emerg Med 2006; 48:358-83. 7. Masoudi FA, Magid DJ, Vinson DR, et al. Implications of the failure to identify high-risk electrocardiogram findings for the quality of care of patients with acute myocardial infarction: results of the Emergency Department Quality in Myocardial Infarction (EDQMI) study. Circulation 2006;114:1565-71. 8. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the doorto-balloon time in acute myocardial infarction. N Engl J Med 2006; 355:2308-20. 9. Rokos IC, French WJ, Koenig WJ, et al. Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on Door-to-Balloon times across 10 independent regions. JACC Cardiovasc Interv 2009;2:339-46. 10. Krumholz HM, Bradley EH, Nallamothu BK, et al. A campaign to improve the timeliness of primary percutaneous coronary

Conclusion
In summary, broad awareness should exist regarding evidence-based triggers for appropriate Cath Lab activation. A diverse group of frontline clinicians making these time-pressured decisions need a comprehensive list of precise criteria, because not all acute MIs have classic ST-

American Heart Journal Volume 160, Number 6

Rokos et al 1003

11.

12.

13.

14.

15.

16. 17.

18.

19.

20.

21.

22.

23.

24.

25.

26.

27.

intervention: Door-to-Balloon: An Alliance for Quality. JACC Cardiovasc Interv 2008;1:97-104. Jacobs AK, Antman EM, Faxon DP, et al. Development of systems of care for ST-elevation myocardial infarction patients: executive summary. Circulation 2007;116:217-30. Peterson ED, Ohman EM, Brindis RG, et al. Development of systems of care for ST-elevation myocardial infarction patients: evaluation and outcomes. Circulation 2007;116:e64-7. Nikus K, Pahlm O, Wagner G, et al. Electrocardiographic classification of acute coronary syndromes: a review by a committee of the International Society for Holter and Non-Invasive Electrocardiology. J Electrocardiol 2010;43:91-103. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined a consensus document of the Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69. Wagner GS, Macfarlane P, Wellens H, et al. AHA/ACCF/HRS scientific statement. Recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/ infarction. Circulation 2009;119:e262-70. Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med 2003;348:933-40. Larson DM, Menssen KM. Sharkey SW, et al. False-positive cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. JAMA 2007;298: 2754-60. Kontos MC, Kurz MC, Roberts CS, et al. An evaluation of the accuracy of emergency physician activation of the cardiac catheterization laboratory for patients with suspected ST-segment elevation myocardial infarction. Ann Emerg Med 2010;55:423-30. Jollis JG, Garvey JL, Monk L, et al. False-positive cath lab activation rates in the RACE regional ST-elevation myocardial infarction program (abstract 1101-286). JACC 2010;55:A109. Rokos IC, Koenig WJ, Tadeo R, et al. Etiologies of inappropriate cardiac catheterization lab activations from pre-hospital electrocardiograms in the Los Angeles County network (abstract 143). Circulation CVQO 2009;2(3 suppl):e33. Swan PY, Nighswonger B, Boswell GL, et al. Factors associated with false-positive emergency medical services triage for percutaneous coronary intervention. West J Emerg Med 2009;10:208-12. Rokos IC, Larson DM, Henry TD, et al. Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks. Am Heart J 2006;152:661-7. Wang K, Asinger RW, Marriott HJ. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 2003;349:2128-35. Otto LA, Aufderheide TP. Evaluation of ST segment elevation criteria for the prehospital electrocardiographic diagnosis of acute myocardial infarction. Ann Emerg Med 1994;23:17-24. Armstrong PW, Fu Y, Westerhout CM, et al. Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2009;53:1503-9. Kudenchuk PJ, Ho MT, Weaver WD, et al. Accuracy of computerinterpreted electrocardiography in selecting patients for thrombolytic therapy. MITI Project Investigators. J Am Coll Cardiol 1991;17: 1486-91. Ting HH, Krumholz HM, Bradley EH, et al. Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association. Circulation 2008;118:1066-79.

28. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Fibrinolytic Therapy Trialists' (FTT) Group. Lancet 1994; 343:311-22. 29. Kontos MC, McQueen RH, Jesse RL, et al. Can myocardial infarction be rapidly identified in emergency department patients who have left bundle-branch block? Ann Emerg Med 2001;37:431-8. 30. Chang AM, Shofer FS, Tabas JA, et al. Lack of association between LBBB and AMI in symptomatic ED patients. Am J Emerg Med 2009; 27:916-21. 31. Sgarbossa EB, Pinski SL, Barbagelata A, et al. Electrocardiographic diagnosis of evolving acute MI in the presence of left bundle-branch block. GUSTO-1 Investigators. N Engl J Med 1996;334:481-7. 32. Tabas JA, Rodriguez RM, Seligman HK, et al. Electrocardiographic criteria for detecting acute myocardial infarction in patients with left bundle branch block: a meta-analysis. Ann Emerg Med 2008;52: 329-36. 33. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15. 34. Pride YB, Tung P, Mohanavelu S, et al. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: A TRITON-Timi 38 sub-study. JACC Intv 2010;3:806-11. 35. Zoghbi GJ, Misra VK, Brott BC, et al. ST-elevation myocardial infarction due to left main culprit lesions: PCI outcomes in cath-PCI registry (abstract 2909-09). JACC 2010;55:A183. 36. Yamaji H, Iwasaki K, Kusachi S, et al. Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography. ST segment elevation in lead aVR with less ST segment elevation in lead V (1). J Am Coll Cardiol 2001;38:1348-54. 37. Rostoff P, Piwowarska W, Gackowski A, et al. Electrocardiographic prediction of acute left main coronary artery occlusion. Am J Emerg Med 2007;25:852-5. 38. de Winter RJ, Verouden NJ, Wellens HJ, et al. A new ECG sign of proximal LAD occlusion. N Engl J Med 2008;359:2071-3. 39. de Zwaan C, Bar FW, Wellens HJ. Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery. Am Heart J 1982;103:730-6. 40. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 1997;336:1629-33. 41. Neumar RW, Nolan JP, Adrie C, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the AHA International Liaison Committee on Resuscitation. Circulation 2008;118:2452-83. 42. Ewy GA, Kern KB. Recent advances in cardiopulmonary resuscitation: cardiocerebral resuscitation. J Am Coll Cardiol 2009;53:149-57. 43. Anyfantakis ZA, Baron G, Aubry P, et al. Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest. Am Heart J 2009;157:312-8. 44. Muller D, Schnitzer L, Brandt J, et al. The accuracy of an out-of-hospital 12-lead ECG for the detection of ST-elevation myocardial infarction immediately after resuscitation. Ann Emerg Med 2008;52:658-64. 45. Dumas F, Cariou A, Manzo-Silberman S, et al. Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circ Cardiovasc Interv 2010;3:200-7. 46. Nichol G, Aufderheide TP, Eigel B, et al. Regional systems of care for out-of-hospital cardiac arrest: a policy statement from the American Heart Association. Circulation 2010;121:709-29.

American Heart Journal Volume 160, Number 6

Rokos et al 1003.e1

Appendix. Online Data Supplement


Title: Appropriate cardiac catheterization lab activation: optimizing electrocardiogram interpretation and clinical decision-making for acute ST-elevation myocardial infarction Authors: Rokos, French, Mattu, Nichol, Farkouh, Reiffel, and Stone. 14 Electrocardiogram (ECG) Examples I. Classic STEMI a. Anterior-STEMI with reciprocal changes proximal LAD occlusion b. Anterior-STEMI without reciprocal changes middle LAD occlusion c. High-lateral STEMI diagonal branch occlusion d. Lateral STEMI left circumflex occlusion II. STEMI-equivalents a. Posterior MI (isolated) b. Left main coronary occlusion: lead aVR STE and infero-lateral STD c. de Winter ST/T-wave complex d. Wellens syndrome (distinguish from de Winter ST/T-wave complex e. LBBB with Sgarbossa criteria III. ST-elevation mimics (STE-mimics) a. Benign early repolarization (BER) b. Acute pericarditis c. Left ventricular aneurysm d. Normal-variant chronic ST-elevation e. Brugada syndrome

1003.e2 Rokos et al

American Heart Journal December 2010

I.a Anterior STEMI with reciprocal changes (IRA = proximal LAD)

I.b Anterior STEMI without reciprocal changes (IRA = middle LAD)

American Heart Journal Volume 160, Number 6

Rokos et al 1003.e3

I.c High Lateral STEMI (IRA = Diagonal branch)

I.d Lateral STEMI (IRA = Left Circumflex)

1003.e4 Rokos et al

American Heart Journal December 2010

II. STEMI-equivalents II.a Posterior MI (Isolated)

II.b Left Main coronary occlusion (LMCO): Lead aVR with ST-elevation and associated infero-lateral ST-depression

American Heart Journal Volume 160, Number 6

Rokos et al 1003.e5

II.c de Winter ST/T-wave complex

II.d Wellens syndrome (This is not a STEMI-equivalent. Example provided to compare with leads V2-V3 of de Winter ST/T-wave complex)

1003.e6 Rokos et al

American Heart Journal December 2010

II.e LBBB MI with Sgarbossa criteria concordance in V2 through V3

III. ST-elevation mimics (STE-mimics) III.a Benign early repolarization (BER)

American Heart Journal Volume 160, Number 6

Rokos et al 1003.e7

III.b Acute pericarditis

III.c Left Ventricular aneurysm

1003.e8 Rokos et al

American Heart Journal December 2010

III.d Normal-variant chronic ST-elevation

III.e Brugada syndrome

Вам также может понравиться